Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
The regulatory function is vital in making safe and effective healthcare products available worldwide. Individuals who ensure regulatory compliance and prepare submissions, as well as those whose main job function is clinical affairs or quality assurance are all considered regulatory professionals.
Resources, news and special offers to support you and your professional development during this difficult time.
One of our most valuable contributions to the profession is the Regulatory Code of Ethics. The Code of Ethics provides regulatory professionals with core values that hold them to the highest standards of professional conduct.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Like all professions, regulatory is based on a shared set of competencies. The Regulatory Competency Framework describes the essential elements of what is required of regulatory professionals at four major career and professional levels.
Download your copy of the new events calendar and see all the online workshops, conferences, RAC exams and European online workshops RAPS has planned for 2021 at a glance.
Registration is now open for RAPS Euro Convergence 2021! Attend to join peers from EU and around the world to gain insights and exchange ideas on the regions most pressing issues.
An invaluable resource for any professional engaged in designing, composing, compiling, or commenting on regulatory documentation
From self-assessments to help you identify your strengths and areas to focus on to reference books and online courses that will help you fill in the gaps in your regulatory knowledge, RAPS has the resources to help you prepare for the RAC exam.
The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
Posted 25 July 2012 | By Alexander Gaffney, RAC
The European Medicines Agency (EMA) has released brand new guidance for manufacturers of veterinary products containing substances with the potential to accumulate both inside and outside of an animal.
EMA's 25 July Guidance on the assessment of persistent, bioaccumulate and toxic (PBT) or very persistent and very bioaccumulate (vPvB) substances in veterinary medicine applies is intended to "provide an assessment strategy" for conducting environmental testing of the products.
The substances are extremely hazardous, in particular because of difficulties determining what constitutes a "safe" dose, EU regulators write. In addition, due to their lengthy half-life they can linger in environmental settings, being absorbed by plants, animals and-eventually-humans as well.
"Persistent, bioaccumulative and toxic or very persistent and very bioaccumulative are combinations of substance properties which give substances the potential to accumulate in remote environments which is difficult to reverse as cessation of emission will not immediately result in a reduction in chemical concentration due to long half-life," EMA explained. The compounds are also characterized by their safety risks, which include "secondary poisoning and extreme toxicity," among other safety hazards, the agency explained.
EMA's guidance asks sponsors to assess the product's impact in animals, how it eventually leaves the animal, how it degrades in the environment and what factors influence its degradation, its toxicity and its bioaccumulative properties. Sponsors will also be required to conduct separate assessments for terrestrial animals and aquatic animals, EMA said.
The guidance goes into effect on 1 February 2013.
Read more:
EMA - Guidance on the assessment of persistent, bioaccumulative and toxic (PBT) or very persistent and very bioaccumulative (vPvB) substances in veterinary medicine
Tags: VPVB, PB, Bioaccumulate, Veterinary, Latest News, guidance
Regulatory Focus newsletters
All the biggest regulatory news and happenings.